Viewing Study NCT00079820


Ignite Creation Date: 2025-12-25 @ 4:10 AM
Ignite Modification Date: 2026-05-23 @ 7:09 AM
Study NCT ID: NCT00079820
Status: COMPLETED
Last Update Posted: 2014-01-13
First Post: 2004-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: H-249-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators